CRPS Treatment Study

Low-Dose Naltrexone (LDN) for the Treatment of Complex Regional Pain Syndrome (CRPS) is currently enrolling participants.

LDN for the Treatment of CRPS is a philanthropically funded study designed to test if LDN can reduce some or all of the signs and symptoms of CRPS/RSD.

Study procedures and treatment are at no cost and you may be compensated for participation.

Principle Investigator: Sean Mackey, MD, PhD

Research Coordinator: Aaron Yue, MD

Sponsor: Reflex Sympathetic Dystrophy Syndrome Association (RSDSA)